NumerixS Investment Technologies Inc - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 231 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
NumerixS Investment Technologies Inc ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$8,000
-88.1%
300
-91.9%
0.00%
-94.1%
Q1 2020$67,000
-81.3%
3,721
-81.6%
0.03%
-51.4%
Q4 2019$358,000
+773.2%
20,200
+745.2%
0.07%
+483.3%
Q2 2019$41,000
+86.4%
2,390
+70.7%
0.01%
+300.0%
Q1 2019$22,000
-43.6%
1,400
-48.1%
0.00%
-76.9%
Q4 2018$39,000
-87.8%
2,700
-84.8%
0.01%
-78.3%
Q3 2018$320,000
+39.1%
17,800
+31.9%
0.06%
+15.4%
Q2 2018$230,000
-56.6%
13,500
-51.8%
0.05%
-60.3%
Q1 2018$530,000
+170.4%
28,000
+189.0%
0.13%
+197.7%
Q4 2017$196,000
-51.4%
9,687
-58.2%
0.04%
-50.6%
Q3 2017$403,000
-52.3%
23,187
-64.8%
0.09%
-28.2%
Q2 2017$845,000
+250.6%
65,887
+254.6%
0.12%
+342.9%
Q1 2017$241,000
-38.4%
18,583
-53.1%
0.03%
-42.9%
Q4 2016$391,000
+1121.9%
39,600
+970.3%
0.05%
+1125.0%
Q2 2016$32,000
-84.3%
3,700
-68.6%
0.00%
-84.0%
Q4 2015$204,000
-32.5%
11,800
-47.6%
0.02%
-28.6%
Q3 2015$302,00022,5000.04%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders